Verde Bio Holdings Stock Current Valuation
| VBHIDelisted Stock | USD 0.0004 0.0002 33.33% |
Valuation analysis of Verde Bio Holdings helps investors to measure Verde Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Verde Bio's price fluctuation is very steady at this time. Calculation of the real value of Verde Bio Holdings is based on 3 months time horizon. Increasing Verde Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Verde Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Verde Pink Sheet. However, Verde Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.0E-4 | Real 3.8E-4 | Hype 5.0E-4 | Naive 5.01E-4 |
The intrinsic value of Verde Bio's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Verde Bio's stock price.
Estimating the potential upside or downside of Verde Bio Holdings helps investors to forecast how Verde pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Verde Bio more accurately as focusing exclusively on Verde Bio's fundamentals will not take into account other important factors: Verde Bio Holdings Company Current Valuation Analysis
Verde Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Verde Bio Current Valuation | 2.42 M |
Most of Verde Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verde Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Verde Bio Holdings has a Current Valuation of 2.42 M. This is 99.99% lower than that of the Energy sector and 99.97% lower than that of the Oil & Gas E&P industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Verde Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verde Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Verde Bio could also be used in its relative valuation, which is a method of valuing Verde Bio by comparing valuation metrics of similar companies.Verde Bio is currently under evaluation in current valuation category among its peers.
Verde Fundamentals
| Return On Equity | -0.53 | |||
| Return On Asset | -0.39 | |||
| Profit Margin | (1.79) % | |||
| Operating Margin | (2.60) % | |||
| Current Valuation | 2.42 M | |||
| Shares Outstanding | 1.35 B | |||
| Shares Owned By Insiders | 2.00 % | |||
| Price To Book | 0.70 X | |||
| Price To Sales | 2.55 X | |||
| Revenue | 720 K | |||
| Gross Profit | 635.38 K | |||
| EBITDA | (2.79 M) | |||
| Net Income | (3.42 M) | |||
| Cash And Equivalents | 101.11 K | |||
| Total Debt | 265.14 K | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (1.15 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 2.88 | |||
| Market Capitalization | 1.55 M | |||
| Total Asset | 5.09 M | |||
| Z Score | 3.0 | |||
| Net Asset | 5.09 M |
About Verde Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verde Bio Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verde Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verde Bio Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Verde Pink Sheet
If you are still planning to invest in Verde Bio Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Verde Bio's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |